Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Pioglitazone hydrochloride may be effective treatment for cognitive dysfunction
caused by radiation therapy.
PURPOSE: This phase I trial is studying the side effects and best dose of pioglitazone
hydrochloride in preventing radiation-induced cognitive dysfunction in treating patients with
brain tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Comprehensive Cancer Center of Wake Forest University Wake Forest University Health Sciences